ABT-450, ritonavir, ombitasvir, and dasabuvir achieves 97% and 100% sustained virologic response with or without ribavirin in treatment-experienced patients with HCV genotype 1b infection - Andreone, P; Colombo, M G; Enejosa, J V (Gastroenterology, 2014)
et al.